Endoscopic Devices - Singapore | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Singapore is anticipated to reach US$55.01m in 2024.
The revenue in this market is expected to exhibit an annual growth rate (CAGR 2024-2029) of 9.51%, which will lead to a market volume of US$86.62m by 2029.
In comparison to the global market, the highest revenue generation is projected to occur the United States, with an expected figure of US$10.39bn in 2024.
In Singapore, the endoscopic devices market is experiencing robust growth driven by increasing demand for minimally invasive surgical procedures and advancements in medical technology.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Singapore is witnessing considerable growth, fueled by advancements in technology, increasing prevalence of chronic diseases, and a rising demand for minimally invasive procedures among healthcare providers and patients alike.

Customer preferences: Consumers in Singapore are shifting towards advanced endoscopic procedures, driven by a growing preference for minimally invasive surgical options that promise quicker recovery times and reduced hospital stays. This trend is particularly pronounced among the aging population, who prioritize less invasive interventions to manage chronic conditions. Additionally, increased health awareness and access to information have led patients to actively seek out innovative treatments, further propelling the demand for sophisticated endoscopic devices tailored to their specific needs.

Trends in the market: In Singapore, the Endoscopic Devices Market is experiencing a notable shift towards advanced imaging technologies and robotic-assisted procedures, enhancing precision and patient outcomes. This trend is fueled by an increasing number of healthcare facilities adopting state-of-the-art endoscopic equipment to cater to the rising demand for minimally invasive surgeries. Furthermore, the integration of artificial intelligence in diagnostic processes is gaining traction, streamlining workflows for healthcare providers. These developments are significant as they not only improve patient satisfaction but also present opportunities for industry stakeholders to innovate and expand their product offerings, ultimately shaping the future of surgical interventions in the region.

Local special circumstances: In Singapore, the Endoscopic Devices Market is uniquely influenced by the country's robust healthcare infrastructure and stringent regulatory environment. The government's commitment to healthcare excellence has led to significant investments in advanced medical technologies, promoting the adoption of innovative endoscopic solutions. Additionally, Singapore's diverse population and high health literacy rate drive demand for minimally invasive procedures, as patients increasingly seek less painful and quicker recovery options. This blend of regulatory support and patient-driven preferences fosters a dynamic environment for industry growth and innovation.

Underlying macroeconomic factors: The Endoscopic Devices Market in Singapore is significantly shaped by macroeconomic factors, including national economic health, global trends in healthcare spending, and the government’s fiscal policies. A strong economy allows for increased healthcare budgets, facilitating investments in cutting-edge medical technologies. Furthermore, global shifts towards minimally invasive surgical techniques enhance local demand for endoscopic solutions, driven by patient preference for quicker recovery times and reduced hospital stays. Additionally, Singapore's strategic position as a medical hub in Asia attracts foreign investment and collaboration, further propelling innovation and market expansion in the endoscopic sector.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.